Uncategorized About Somnogen

About Somnogen


Somnogen is an early stage pharmaceutical Company, launched by highly acclaimed sleep research expert, S.R. Pandi-Perumal. Its global headquarters are located in Toronto, Canada and its operational headquarters are scheduled to launch in south India during Q1, 2011. The Company aspires to develop and sell products in the rapidly growing India market and beyond. Somnogen specializes in sleep related therapeutic medications and treatments for sleep disorders, such as insomnia.

Sleep is an important issue from personal, societal, and public health standpoints. Somnogen is positioned not only as pharmaceutical Company, but also as a life-style brand. In addition to selling sleep therapeutics, we strive to educate the public about healthy, “well-rested” living. Treatment of sleep disorders, particularly insomnia is uncommon and the sleep therapy market is reasonably unknown in India; based on our research, the vast majority of the general public remains unaware of sleeping disorders and/or available remedies. As a sleep focussed Company guided by leaders in the field, Somnogen has the opportunity to establish itself as pioneer in this niche industry. Assuming success in India, Somnogen will use its resources and reputation to expand to neighbouring markets before going global.

Share This Post

Corporate Social Responsibility

image Somnogen will develop a unique culture thereby giving back is both an individual and society. Such requests will be evaluated on individual basis and resources will be coordinated – including product donations, gifts and grants – to create timely and relevant responses tailored to meet individual, local, national or international challenges.
 group of doctors

Login Form